{"id":"W4400933413","doi":"10.1038/s41416-024-02796-3","title":"COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer","year":2024,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Bevacizumab; Medicine; Durvalumab; FOLFOX; Oxaliplatin; Colorectal cancer; Internal medicine; Confidence interval; Adverse effect; Oncology; Cancer; Surgery; Chemotherapy; Nivolumab; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001678664,0.001448807,0.00233146,0.0005146136,0.0004062591,0.001097628,0.001224511,0.001496244,0.006951971],"category_scores_gemma":[0.002333878,0.0008219249,0.001352546,0.0004797056,0.001152031,0.0008668702,0.0006080197,0.002554594,0.0008920545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001794587,"about_ca_system_score_gemma":0.002542058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004166949,"about_ca_topic_score_gemma":0.01269432,"domain_scores_codex":[0.9991987,0.0004479378,0.00004154283,0.00012294,0.00007711861,0.0001117499],"domain_scores_gemma":[0.9988629,0.0002715315,0.0001989289,0.00007295009,0.00007530957,0.000518495],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9742536,0.008766989,0.0005321295,0.0005368668,0.0006280102,0.00004038324,0.00005490837,0.0002441237,0.002406862,0.00006890068,0.0005942706,0.01187301],"study_design_scores_gemma":[0.927447,0.07038288,0.001151086,0.00001928663,0.0002230108,0.00002314954,0.00001586184,0.0001834475,0.0001279202,0.00004253136,0.0003726643,0.00001117159],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906986,0.002418648,0.0002273511,0.0004469051,0.0003474949,0.003479796,0.000597721,0.00006784269,0.001715702],"genre_scores_gemma":[0.9881088,0.002119142,0.001030703,0.001005303,0.0003600483,0.002971383,0.001161977,0.00001973885,0.003222899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006951971,"threshold_uncertainty_score":0.0232566,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0119592495075272,"score_gpt":0.2942578742307003,"score_spread":0.2822986247231731,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}